Wiebe et al. Steroids <=5mg/day not associated negative effect on BMD. Of course steroid-related increase in fracture risk is not fully captured by BMD effect @RheumNow #ACR22 Abstr#1318 https://t.co/Ond5gzopRa https://t.co/HX2AUyQmsf

• Low-Dose Prednisolone (≤5 Mg/d) Is Not Associated with Deleterious Effects on B…

#ACR22 Abstr#1569 Lung complications are common in #VEXAS but what are the common radiologic findings? A cohort study in 22 men showed abnormalities were found in most patients but were non-specific. Most commonly parenchymal changes (73%) @RheumNow https://t.co/kjYSHON2yN

Carter et al. Case series showing rapid effect of anifrolumab in refractory discoid lupus and SCLE. @RheumNow #ACR22 Abstr#0974 https://t.co/RjnNxjGJoP…

• Rapid and Effective Response to Immunosuppression in Treating Macrophage Activa…

Pala et al. Increasing disease activity by CDAI associated increasing patient-reported cognitive dysfunction in RA. More pronounced in younger patients. @RheumNow #ACR22 Abstr#1397 https://t.co/eRFxe27qgq https://t.co/NUtTaAcrik

• The Impact of Disease Activity on Patient-Reported Cognitive Dysfunction in Rhe…

Meng et al. ESR/CRP and steroid associated increased risk of MACE in IA. NSAIDs/COX-2 and MTX associated reduced risk of MACE in IA. @RheumNow #ACR22 Abstr#1207 https://t.co/OvjNZkpWpy https://t.co/9NMIJPcV9G

• Risk Factors for Major Cardiovascular Events (MACE) in Inflammatory Arthritis: …

Ab1486 #ACR22 @Keith_Colaco: Disease-specific CV Risk Prediction Model for PsO, PsA Prediction base model w only traditional CV risks excellent (AUC 85.5) Expanded model w damaged jts did not improve risk discrimination @Rheumnow https://t.co/DMlOreW9zK

Spiera et al. Resolution PMR in SAPHYR trial IL-6i sarilumab. Week 52, 81% vs 57% with no signs/symptoms More in PBO arm needed rescue GCs 58.6% vs 32.2% @RheumNow #ACR22 Abstr#1543 https://t.co/3Sr8aB2SpC https://t.co/mjuzNFWcdn

• Resolution of PMR Signs and Symptoms in Patients Treated with Sarilumab: A Phas…

Katz @GuyKatzMD et al. Coronary involvement in IgG4-RD. 13 cases, all male, median 11 years disease. All elevated serum IgG4. Aneurysms 8/13, arteritis 9/13 periarteritis 11/13. @RheumNow #ACR22 Abstr#1571 https://t.co/At7Gw2kRUp https://t.co/zcXc6oUS0f

• Coronary Arteritis and Periarteritis Secondary to IgG4-related Disease in a Lar…

Singh @NamrataRheum et al. 27,421 RA patients, 8225 on b/tsDMARD. b/tsDMARDs did not increase risk of lymphoma. IR 1.68/1000PY (95% CI 1.5-1.9) on csDMARD vs IR 1.73/1000PY (95%CI 1.4-2.1) on b/tsDMARD. @RheumNow #ACR22 Abstr#1210 https://t.co/3Uvz3mvsGM https://t.co/6k3Vqb21KF

• Use of Biologic or Targeted Synthetic Disease Modifying Anti-rheumatic Drugs an…

Are preexisting autoimmune dx pts okay for PD-1i/CTLA-4i combo immunoRx (vs PD-1i single agent)? Common question in practice for your rheum pts who get cancer Combo ICI means: de novo irAE: double risk flares: same risk Give our pts what they need! ABST0757 #ACR22 @RheumNow https://t.co/Vs1AoM54Ut

Ab1508 #ACR22 Enthesitis on PET/CT 20 untreated PsA pts w/ total body PET/CT All 20 (100%) pts had entheseal inflammation 127/543 (~1/4) entheses showed inflammation @RheumNow https://t.co/OQCBWW70bt

Zheng et al. Celiac disease more common in SLE aOR 2.88 (95%CI 2.60 –3.31). More common in white females. Assoc higher hospitalization cost and increased LOS @RheumNow #ACR22 Abstr#1192 https://t.co/kdwLmpIxNN https://t.co/ZdQJQn3QIF

• Celiac Disease in Patients with Systemic Lupus Erythematosus: An Analysis of Na…

Abs 1011 examined fracture incidence rates in AS patients over time in VA cohort - Rate of fractures in AS pts 2.1 per 1000 PY --> 22.8 (1999 --> 2021) vs Comparators 0.4 --> 8.3 - Post TNF era fracture rates increased AS > comparators @RheumNow #ACR22 https://t.co/eUxoTavHGV

Table by ⁦@CuoghiE⁩ on how long to wait off #teratogenic meds before trying to conceive: note 2 years fr leflunomide unless a cholestyramine washout is done #ReproductiveRheum #ACR22 @rheumnow https://t.co/l4hIBQ5XN5

A future rheumatologist attending the #ACR22 Plenary session virtually to keep up with the latest information. ⁦@RheumNow⁩ https://t.co/ttYr4iwTB8